You are viewing: US Pharmaceutical Manufacturing Equipment Market analysis

The US Pharmaceutical Manufacturing Equipment Market was valued at $2806.4 Million in 2026 and projected to reach to $4183.3 Million by 2031, representing a compound annual growth rate of 6.9%. The US pharmaceutical manufacturing equipment market is poised for sustained growth through 2031, driven by the industry's commitment to modernizing production capabilities and meeting evolving regulatory standards.

US Pharmaceutical Manufacturing Equipment Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Pharmaceutical Manufacturing Equipment Market Trends and Insights

  • This expansion reflects the US pharmaceutical industry's increasing investment in advanced manufacturing technologies, automation, and quality control systems to meet stringent regulatory requirements and rising production demands.
  • The US market benefits from strong domestic pharmaceutical R&D capabilities, FDA compliance standards, and the presence of leading equipment manufacturers. Driving the US market's 6.9% compound annual growth rate are factors including the shift toward continuous manufacturing processes, heightened demand for personalized medicine production capabilities, and modernization of existing manufacturing facilities.
  • The US pharmaceutical sector's focus on reducing production costs while maintaining quality standards accelerates adoption of innovative equipment solutions.
  • Additionally, the US government's emphasis on domestic pharmaceutical supply chain resilience and nearshoring initiatives further supports market expansion through 2031..

Key Market Statistics

  • CAGR (2026-2031) 6.9% CAGR
  • Market Size, 2026 ~USD 2806.4 Million
  • Forecast, 2031 ~USD 4183.3 Million
  • Country US

US Pharmaceutical Manufacturing Equipment Market Overview

Market Valuation Growth :

The US pharmaceutical manufacturing equipment market is valued at $2,806.4 million in 2026 and is projected to reach $4,183.3 million by 2031, representing a robust 6.9% CAGR over the forecast period.

Regulatory Compliance Drivers :

US pharmaceutical manufacturers are increasingly investing in advanced manufacturing equipment to comply with FDA regulations and GMP standards, driving demand for automated quality control and inspection systems.

Automation & Technology Adoption :

The US market is witnessing accelerated adoption of Industry 4.0 technologies, including IoT-enabled equipment, real-time monitoring systems, and AI-powered manufacturing solutions to enhance production efficiency.

Production Capacity Expansion :

Rising domestic pharmaceutical production demand, coupled with nearshoring initiatives and supply chain resilience strategies, is fueling investments in new manufacturing facilities and equipment upgrades across the US.

US Pharmaceutical Manufacturing Equipment Market Dynamics

  • Manufacturers are prioritizing investments in automation, continuous manufacturing technologies, and advanced analytics to improve operational efficiency and product quality.
  • The shift toward personalized medicine and biologics production is also creating demand for specialized, flexible manufacturing equipment.
  • Additionally, government initiatives supporting domestic pharmaceutical production and supply chain independence are expected to accelerate capital expenditures in manufacturing infrastructure throughout the forecast period..

Related Ecosystem

Industrial Automation

Top Technologies
  • Sensors
  • Image Sensors
  • Manufacturing Execution System (MES)
  • Actuators
  • Flow Sensors
Top Companies
  • Siemens ag
  • ABB India Limited
  • Emerson Electric Co.
  • HONEYWELL INTERNATIONAL INC.
  • SCHNEIDER ELECTRIC SE

    Key Takeaways

    • The US pharmaceutical manufacturing equipment market will grow from $2,806.4M in 2026 to $4,183.3M in 2031, representing a 6.9% CAGR.
    • US regulatory compliance requirements and FDA standards drive continuous investment in advanced manufacturing equipment and automation technologies.
    • The US market is increasingly adopting continuous manufacturing and personalized medicine production capabilities to enhance efficiency and product quality.
    • Government initiatives promoting domestic pharmaceutical supply chain resilience and nearshoring are accelerating equipment modernization across US facilities.

    Pharmaceutical Manufacturing Equipment Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment PACKAGING MACHINES (Equipment Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.2% from 2026 to 2031
    Largest Segment AUTOMATIC (Technology)
    Market Size Base Year (Billions) ~USD 21.18 (2026)
    Revenue Forecast (Billions) ~USD 28.62 (2031)
    Segments Covered Equipment Type, End-Product Type, Technology

    US Pharmaceutical Manufacturing Equipment Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Equipment Type

    • Extrusion Equipment
    • Filling Machines
    • Granulation Equipment
    • Inspection Equipment
    • Milling Equipment
    • Mixing & Blending Machines
    • Packaging Machines
    • Spray Drying Equipment
    • Sterilization Equipment
    • Tablet Compression Presses

    By End-Product Type

    • Liquid
    • Solid

    By Technology

    • Automatic
    • Semi-Automatic

    Target Audience

    • Pharmaceutical Equipment Manufacturers : Need US-specific market data to develop targeted product strategies, identify growth segments, and optimize sales and distribution channels for the American pharmaceutical manufacturing sector.
    • Pharmaceutical Production Facilities : Require market insights to benchmark capital expenditure plans, evaluate equipment upgrade priorities, and align manufacturing investments with industry trends and regulatory requirements in the US.
    • Private Equity & Investment Firms : Seek detailed US market forecasts and growth drivers to evaluate investment opportunities in pharmaceutical equipment manufacturers and production facility operators with strong domestic growth potential.
    • Supply Chain & Operations Managers : Need comprehensive US market data to assess equipment sourcing strategies, supplier selection, and manufacturing technology investments that support nearshoring and supply chain resilience goals.
    • Regulatory & Quality Compliance Officers : Require insights into FDA-compliant equipment trends and automation technologies to ensure manufacturing facilities meet evolving regulatory standards and maintain competitive operational efficiency.

    Key Companies in the US Pharmaceutical Manufacturing Equipment Market

    CompanyHQOwnershipStrongest segments
    GEA GROUP AKTIENGESELLSCHAFTUnited StatesPublic CompanySeparation & Flow Technologies,Liquid & Power Technologies,Food & Health Technologies,
    KöRBER AGGermanyPrivate CompanySupply chain software, automation, voice, robotics, and material handling,Pharma machinery, equipment, and related software,Technologies: measuring instruments, flavors, food and beverage, and e-mobility equipment,
    IMA INDUSTRIA MACCHINE AUTOMATICHE SPAItalyPrivate CompanyPharmaceutical processing and packaging systems,Food, dairy, and beverage packaging lines,Tea, coffee, and related portioning systems,
    ACGBermudaPublic CompanyInsurance,Reinsurance,Mortgage,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    ELIZABETH COMPANIESUnited StatesPrivate CompanyPrestige and heritage fragrances,Licensed designer and celebrity fragrances,Skincare (Elizabeth Arden, Ceramide, Prevage, Eight Hour, Pro),
    FREUNDJapanPrivate CompanyPharmaceutical granulation and coating equipment,Plant engineering and integrated systems,Pharmaceutical excipients,

    GEA GROUP AKTIENGESELLSCHAFT

    GEA GROUP AKTIENGESELLSCHAFT is a publicly traded company founded in 1881 with 19,670 employees operating in the United States.

    KöRBER AG

    KÖRBER AG is a German private company founded in 1946 with 10,665 employees.

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA is an Italian private company founded in 1961 with 6,121 employees.

    ACG

    ACG is a publicly traded company based in Bermuda founded in 1995 with 8,000 employees.

    THERMO FISHER SCIENTIFIC INC.

    THERMO FISHER SCIENTIFIC INC. is a publicly traded United States company founded in 1956 with 125,000 employees.

    ELIZABETH COMPANIES

    ELIZABETH COMPANIES is a United States-based private company founded in 1910 with 2,150 employees.

    FREUND

    FREUND is a Japan-based private company founded in 1964 with 427 employees.

    Reasons to Buy this Report

    • Accurate US Market Sizing : Obtain precise valuation data specific to the US market ($2,806.4M in 2026) with detailed forecasts through 2031, enabling accurate budget allocation and investment planning for US operations.
    • Regulatory & Compliance Insights : Understand how FDA regulations and GMP requirements are shaping equipment demand in the US, helping you align product development and sales strategies with compliance-driven purchasing decisions.
    • Competitive Landscape Analysis : Identify key growth drivers specific to the US market, including automation trends, nearshoring initiatives, and domestic production expansion, to benchmark against competitors and capture market opportunities.
    • Technology Adoption Trends : Gain insights into US pharmaceutical manufacturers' adoption of Industry 4.0 technologies, continuous manufacturing, and biologics production equipment to inform product innovation and market positioning.
    • Strategic Investment Guidance : Leverage 6.9% CAGR projections and market expansion data to make informed decisions on facility investments, equipment upgrades, and market entry strategies within the US pharmaceutical sector.

    Frequently asked questions

    What is the current size of the US pharmaceutical manufacturing equipment market?

    The US pharmaceutical manufacturing equipment market is valued at $2,806.4 million in 2026 and is expected to reach $4,183.3 million by 2031.

    What is the projected growth rate for the US market through 2031?

    The US pharmaceutical manufacturing equipment market is projected to grow at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2031.

    What factors are driving growth in the US pharmaceutical manufacturing equipment market?

    Key drivers include FDA compliance requirements, adoption of continuous manufacturing processes, demand for personalized medicine production, facility modernization, and government initiatives supporting domestic pharmaceutical supply chain resilience.

    How does the US market compare to global pharmaceutical manufacturing equipment trends?

    The US market grows at 6.9% CAGR, outpacing the global average of 6.2%, reflecting stronger domestic investment in advanced manufacturing technologies and regulatory compliance infrastructure.

    What types of equipment are most in demand in the US pharmaceutical manufacturing sector?

    The US market shows strong demand for automation systems, quality control equipment, continuous manufacturing systems, and advanced analytical instruments that support FDA compliance and production efficiency.

    RESEARCH METHODOLOGY

    The research process for this study involved the systematic gathering, recording, and analysis of data on customers and companies operating in the pharmaceutical manufacturing equipment market. This process involved the extensive use of secondary sources, directories, and databases (Factiva and Oanda) to identify and collect valuable information for the comprehensive, technical, market-oriented, and commercial study of the pharmaceutical manufacturing equipment market. In-depth interviews were conducted with primary respondents, including experts from core and related industries, as well as preferred manufacturers, to obtain and verify critical qualitative and quantitative information and assess growth prospects. Key players in the pharmaceutical manufacturing equipment market were identified through secondary research, and their market rankings were determined through a combination of primary and secondary research. This research involved studying the annual reports of top players and conducting interviews with key industry experts, including CEOs, directors, and marketing executives.

    Secondary Research

    Various sources were utilized in the secondary research process to identify and collect information relevant to this study. These include company annual reports, press releases, investor presentations, white papers, technology journals, certified publications, articles by recognized authors, directories, and databases. Secondary research was primarily used to gather key information about the industry’s value chain, the total pool of market players, market classification according to industry trends at the most detailed level, regional markets, and key developments from both market and technology-oriented perspectives.

    Primary Research

    Primary research was conducted to identify the segmentation types, key players, competitive landscape, and key market dynamics, including drivers, restraints, opportunities, challenges, and industry trends, as well as key strategies adopted by players operating in the pharmaceutical manufacturing equipment market. Extensive qualitative and quantitative analyses were performed on the complete market engineering process to list key information and insights throughout the report.
    Extensive primary research has been conducted after gaining insights into the pharmaceutical manufacturing equipment market scenarios through secondary research. Several primary interviews were conducted with experts from the demand (region) and supply side (equipment type, end-product type, and technology) across four major geographic regions: North America, Europe, Asia Pacific, and RoW. Approximately 60% and 40% of the primary interviews were conducted from the supply and demand sides, respectively. These primary data have been collected through questionnaires, emails, and telephonic interviews.

    Pharmaceutical Manufacturing Equipment Market Size, and Share

    Notes: The three tiers of companies have been defined based on their total/segmental revenue as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million–USD 1 billion, and Tier 3 = <USD 500 million.
    Other designations include sales, marketing, and product managers.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    In the complete market engineering process, top-down and bottom-up approaches and several data triangulation methods were implemented to estimate and validate the size of the pharmaceutical manufacturing equipment market and various other dependent submarkets. Key players were identified through secondary research, and their market share in the respective regions was determined through a combination of primary and secondary research. This entire research methodology involved studying the annual and financial reports of the top players, as well as conducting interviews with experts (CEOs, VPs, directors, and marketing executives) to gather key insights (both quantitative and qualitative).

    All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study were accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Pharmaceutical Manufacturing Equipment Market : Top-Down and Bottom-Up Approach

    Pharmaceutical Manufacturing Equipment Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size through the estimation process, as explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, market breakdown and data triangulation procedures were employed, as applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market has been validated using both top-down and bottom-up approaches.

    Market Definition

    The pharmaceutical manufacturing equipment market covers the global ecosystem involved in the development, production, processing, and packaging of pharmaceutical products across solid and liquid formulations. It includes machinery and integrated systems designed to ensure precision and sterility. These systems maintain regulatory compliance and operational efficiency. Equipment supports activities from raw material handling to final packaging. Manufacturers use these systems to maintain product quality. Large-scale and contract facilities rely on advanced machinery to optimize throughput.

    The pharmaceutical manufacturing equipment market is segmented by equipment type, such as packaging machines and filling machines. Spray drying equipment and mixing & blending machines are also included. Milling equipment and extrusion equipment support formulation processes. Tablet compression presses and inspection equipment ensure quality control. Granulation and sterilization equipment are also key categories. By end-product type, the market includes solid and liquid formulations. By technology, the market consists of semi-automatic and automatic systems. Automation improves productivity and reduces manual intervention. Growing pharmaceutical production supports equipment demand. Expansion of biologics and generics manufacturing drives modernization. Investment in advanced manufacturing technologies strengthens global market growth.

    Key Stakeholders

    • Pharmaceutical manufacturing equipment manufacturers
    • End users
    • Automation consultants
    • Research organizations
    • Technology investors
    • Technology standards organizations, forums, alliances, and associations
    • Process automation and instrumentation solution and product suppliers
    • Instrumentation and automation products’ original equipment manufacturers (OEMs)
    • Energy industry associations

    Report Objectives

    • To describe and forecast the pharmaceutical manufacturing equipment market, by equipment type, end-product type, and technology, in terms of value
    • To forecast the market size for four key regions, namely North America, Europe, Asia Pacific, and the Rest of the World (RoW), along with their country-level analyses, in terms of value
    • To estimate the market size, by equipment type, in terms of volume
    • To provide detailed information regarding the major factors influencing the growth of the market, namely, drivers, restraints, opportunities, and challenges
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
    • To study the complete value chain of the pharmaceutical manufacturing equipment ecosystem, along with market trends and use cases
    • To analyze opportunities for stakeholders in the market by identifying high-growth segments of the market
    • To strategically profile key players and comprehensively analyze their core competencies2, along with detailing the competitive landscape for market leaders
    • To analyze competitive developments, such as product launches, mergers, acquisitions, partnerships, collaborations, and expansions, in the pharmaceutical manufacturing equipment market.
    • To benchmark market players using the company evaluation matrix, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide information on Porter’s five forces analysis, pricing analysis, trade analysis, investment and funding scenario, key conferences and events, regulatory landscape, ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs of various equipment types, interconnected markets and cross-sector opportunities, macroeconomic outlook, and the impact of AI, and the impact of 2025 US tariff
    • To benchmark market players using the company evaluation quadrant, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide a macroeconomic outlook for all regions covered in this report
    • To provide information on ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs from various applications, interconnected markets, and cross-sector opportunities, and the impact of AI and its use cases, and the 2025 US tariff impact

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

     

    Get the Full Pharmaceutical Manufacturing Equipment Market Report

    Full forecast, segment splits, and company analysis for all Pharmaceutical Manufacturing Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status